Publications

  1. Breen WG, Blanchard MJ, Rao AN, Daniels DJ, Buckner JC, Laack NNI. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy. Pediatr Blood Cancer. 2017 Nov; 64 (11) Epub 2017 July 11
    View PubMed
  2. Zhu C, Olson KA, Roth M, Geller DS, Gorlick RG, Gill J, Laack NN, Randall RL. Provider views on the management of Ewing sarcoma of the spine and pelvis. J Surg Oncol. 2017 Oct 16 [Epub ahead of print]
    View PubMed
  3. Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Is the blood-brain barrier really disrupted in all glioblastomas? - A critical assessment of existing clinical data. Neuro Oncol. 2017 Sep 07 Epub 2017 Sept 07
    View PubMed
  4. Ahmed SK, Robinson SI, Arndt CAS, Petersen IA, Haddock MG, Rose PS, Issa Laack NN. Pelvis Ewing sarcoma: Local control and survival in the modern era. Pediatr Blood Cancer. 2017 Sep; 64 (9) Epub 2017 Feb 28
    View PubMed
  5. Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Gorlick RG, Laack NNI. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2017 Aug 24 [Epub ahead of print]
    View PubMed
  6. Youland RS, Kreofsky CR, Schomas DA, Brown PD, Buckner JC, Laack NN. The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma. J Neurooncol. 2017 Aug 23;
    View PubMed
  7. Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients. Int J Radiat Oncol Biol Phys. 2017 Aug 02 [Epub ahead of print]
    View PubMed
  8. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 Aug; 18 (8):1049-1060 Epub 2017 July 04
    View PubMed
  9. Youland RS, Schomas DA, Brown PD, Parney IF, Laack NNI. Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience. J Neurooncol. 2017 Jun; 133: (2)339-346.
    View PubMed
  10. Buckner J, Giannini C, Eckel-Passow J, Lachance D, Parney I, Laack N, Jenkins R. Management of diffuse low-grade gliomas in adults - use of molecular diagnostics. Nat Rev Neurol. 2017 Jun; 13: (6)340-351.
    View PubMed
  11. Kirkpatrick JP, Laack NN, Shih HA, Gondi V. Management of GBM: a problem of local recurrence. J Neurooncol. 2017 Apr 04 [Epub ahead of print]
    View PubMed
  12. Pospisil P, Kazda T, Hynkova L, Bulik M, Dobiaskova M, Burkon P, Laack NN, Slampa P, Jancalek R. Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study. Radiother Oncol. 2017 Mar; 122 (3):373-379 Epub 2017 Jan 04
    View PubMed
  13. Reynolds MM, Arnett AL, Parney IF, Kumar R, Laack NN, Maloney PR, Kozelsky TF, Garces YI, Foote RL, Pulido JS. Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases. Int J Retina Vitreous. 2017; 3:17.
    View PubMed
  14. Birckhead B, Sio TT, Pollock BE, Link MJ, Laack NN. Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series. J Neurooncol. 2016 Dec; 130: (3)553-560.
    View PubMed
  15. Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. Ann Surg Oncol. 2016 Oct; 23: (11)3541-3547.
    View PubMed
  16. Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 Oct; 63 (10):1771-9 Epub 2016 June 14
    View PubMed
  17. Ahmed SK, Kruse JJ, Beltran C, Laack NN. Highly Conformal Hybrid Forward and Inverse Planned Intensity Modulated Radiation Therapy for Supine Craniospinal Irradiation (CSI): Long-term Results and Implications for Pencil Beam Proton Planning. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)E557.
    View PubMed
  18. Youland RS, Seaberg MH, Brinkmann DH, Galanis E, Kaufmann TJ, Laack NN. Validation of Updated Response Assessment Criteria for Glioblastoma (GBM) and Implications for Clinical Trial Reporting. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)E64.
    View PubMed
  19. Breen W, Bancos I, Bible KC, Young WF, Laack NN, Foote RL, Hallemeier CL. External Beam Radiation Therapy for Advanced/Unresectable Malignant Paraganglioma and Pheochromocytoma. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)E64.
    View PubMed
  20. Funk RK, Blanchard MJ, Williamson EE, Young PM, McCollough CH, Tasson AM, Leng S, Laack NN. A Prospective Pilot Study Evaluating Feasibility and Utility of ECG-gated CT Angiography for Coronary-Sparing Radiation Therapy Planning in Mediastinal Lymphoma. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S38.
    View PubMed
  21. Kreofsky CR, Youland RS, Buckner JC, Uhm JH, Lachance DH, Laack NN. Single-Institution Experience of Low-Grade Glioma Patient Outcomes Eligible for RTOG 9802. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S90.
    View PubMed
  22. Chihak MA, Ahmed SK, Lachance DH, Nageswara Rao AA, Laack NN. Patterns of failure and optimal radiotherapy target volumes in primary intradural extramedullary Ewing sarcoma. Acta Oncol. 2016 Aug; 55: (8)1057-61.
    View PubMed
  23. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6: (4)e117-26.
    View PubMed
  24. Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Mar; 63: (3)493-8.
    View PubMed
  25. Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Adv Radiat Oncol. 2016 Jan-Mar; 1 (1):76-81 Epub 2015 Dec 19
    View PubMed
  26. Stish BJ, Ahmed SK, Rose PS, Arndt CA, Laack NN. Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing Sarcoma. Pediatr Blood Cancer. 2015 Dec; 62: (12)2189-96.
    View PubMed
  27. Vogelbaum MA, Hu C, Peereboom DM, Macdonald DR, Giannini C, Suh JH, Jenkins RB, Laack NN, Brachman DG, Shrieve DC, Souhami L, Mehta MP. Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131. J Neurooncol. 2015 Sep; 124: (3)413-20.
    View PubMed
  28. Kumar R, Laack N, Pollock BE, Link M, O'Neill BP, Parney IF. Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. World Neurosurg. 2015 Aug; 84: (2)390-7.
    View PubMed
  29. Abdulaziz M, Mallory GW, Bydon M, De la Garza Ramos R, Ellis JA, Laack NN, Marsh WR, Krauss WE, Jallo G, Gokaslan ZL, Clarke MJ. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity. Neurosurg Focus. 2015 Aug; 39: (2)E8.
    View PubMed
  30. Rollmann DC, Novotny PJ, Petersen IA, Garces YI, Bauer HJ, Yan ES, Wahner-Roedler D, Vincent A, Sloan JA, Issa Laack NN. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis. Int J Radiat Oncol Biol Phys. 2015 Jul 1; 92(3):650-8. Epub 2015 Apr 28.
    View PubMed
  31. Laack NN, Sarkaria JN, Buckner JC. Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma? Semin Radiat Oncol. 2015 Jul; 25: (3)197-202.
    View PubMed
  32. Elwood K, Laack N, Warad DM, Keating G, Eckel L, Nageswara Rao AA. Injury to insult: infarction after radiotherapy in the treatment of pediatric brain tumor. Pediatr Neurol. 2015 May; 52: (5)552-3.
    View PubMed
  33. Kazda T, Pospisil P, Vrzal M, Sevela O, Prochazka T, Jancalek R, Slampa P, Laack NN. Volumetric modulated arc therapy for hippocampal-sparing radiotherapy in transformed low-grade glioma: A treatment planning case report. Cancer Radiother. 2015 May; 19: (3)187-91.
    View PubMed
  34. Lageman SK, Brown PD, Anderson SK, Lachance DH, Yan E, Laack NN, Cerhan JH. Exploring primary brain tumor patient and caregiver needs and preferences in brief educational and support opportunities. Support Care Cancer. 2015 Mar; 23: (3)851-9.
    View PubMed
  35. Nwachukwu CR, Youland RS, Chioreso C, Wetjen N, NageswaraRao A, Keating G, Laack NN. Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs). J Neurooncol. 2015 Feb; 121: (3)599-607.
    View PubMed
  36. Kazda T, Hardie JG, Pafundi DH, Kaufmann TJ, Brinkmann DH, Laack NN. Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure. J Neurooncol. 2015; 122(1):197-203.
    View PubMed
  37. Robinson SI, Ahmed SK, Okuno SH, Arndt CA, Rose PS, Laack NN. Clinical outcomes of adult patients with relapsed Ewing sarcoma: a 30-year single-institution experience. Am J Clin Oncol. 2014 Dec; 37(6):585-91.
    View PubMed
  38. Lester RA, Brown LC, Eckel LJ, Foote RT, NageswaraRao AA, Buckner JC, Parney IF, Wetjen NM, Laack NN. Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor. J Neurooncol. 2014 Nov; 120(2):371-9. Epub 2014 Aug 13.
    View PubMed
  39. Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN. Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):705-6. Epub 2014 Sep 26.
    View PubMed
  40. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Issa Laack NN. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease. Am J Clin Oncol. 2014 Oct; 37(5):423-9.
    View PubMed
  41. Kizilbash SH, Giannini C, Voss JS, Decker PA, Jenkins RB, Hardie J, Laack NN, Parney IF, Uhm JH, Buckner JC. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. J Neurooncol. 2014 Oct; 120: (1)85-93.
    View PubMed
  42. Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder M, Yan E, Laack N. Once-daily radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):997-1003. Epub 2014 Apr 07.
    View PubMed
  43. Tasson A, Beltran C, Laack N, Childs S, Tryggestad E, Whitaker T. SU-E-T-337: Treatment Planning Study of Craniospinal Irradiation with Spot Scanning Proton Therapy. Med Phys. 2014 Jun; 41: (6)302.
    View PubMed
  44. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4: (2)e143-9.
    View PubMed
  45. Brown PD, Blanchard M, Jethwa K, Flemming KD, Brown CA, Kline RW, Jacobson DJ, St Sauver J, Pollock BE, Garces YI, Stafford SL, Link MJ, Erickson D, Foote RL, Laack NN. The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study. Neurooncol Pract. 2014 Mar; 1: (1)22-28.
    View PubMed
  46. Call JA, Naik M, Rodriguez FJ, Giannini C, Wu W, Buckner JC, Parney IF, Laack NN. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol. 2014 Feb; 37: (1)1-7.
    View PubMed
  47. Ahmed KA, Laack NN, Eckel LJ, Orme NM, Wetjen NM. Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic. Am J Clin Oncol. 2014 Feb; 37: (1)51-6.
    View PubMed
  48. Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, Burkon P, Slavik M, Hynkova L, Slampa P, Laack NN. Why and how to spare the hippocampus during brain radiotherapy: The developing role of hippocampal avoidance in cranial radiotherapy. Radiat. oncol. 2014; 9(1):139.
    View PubMed
  49. Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014; 2014:418270.
    View PubMed
  50. Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN. Adult low-grade glioma: 19-year experience at a single institution. Am J Clin Oncol. 2013 Dec; 36: (6)612-9.
    View PubMed
  51. Rooney JW, Laack NN. Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation. CNS Oncol. 2013 Nov; 2(6):531-41.
    View PubMed
  52. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36(5):509-13.
    View PubMed
  53. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D, Radiation Therapy Oncology Group (RTOG). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013 Oct; 15: (10)1429-37.
    View PubMed
  54. Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87: (1)73-80.
    View PubMed
  55. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Aug; 15: (8)1058-67.
    View PubMed
  56. Youland RS, Schomas DA, Brown PD, Nwachukwu C, Buckner JC, Giannini C, Parney IF, Laack NN. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol. 2013 Aug; 15: (8)1102-10.
    View PubMed
  57. Nagata S, Shen RK, Laack NN, Inwards CY, Wenger DE, Amrami KK. Chondrosarcoma arising within a radiation-induced osteochondroma several years following childhood total body irradiation: case report. Skeletal Radiol. 2013 Aug; 42: (8)1173-7.
    View PubMed
  58. Merchant TE, Hodgson D, Laack NN, Wolden S, Indelicato DJ, Kalapurakal JA, COG Radiation Oncology Discipline Committee. Children's Oncology Group's 2013 blueprint for research: radiation oncology. Pediatr Blood Cancer. 2013 Jun; 60: (6)1037-43.
    View PubMed
  59. Beltran C, Fernandez D, Laack N. SU-E-T-665: Investigation of Uniform Planning Margin for Intensity Modulated Proton Therapy of Pediatric Brain Tumors. Med Phys. 2013 Jun; 40: (6Part21)359.
    View PubMed
  60. Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol. 2013 Apr; 35(3):197-205.
    View PubMed
  61. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85: (4)971-7.
    View PubMed
  62. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013 Jan; 111: (1)11-8.
    View PubMed
  63. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Laack NN. Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease. Sarcoma. 2013; 2013:681425.
    View PubMed
  64. Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg. 2012 Nov; 117: (5)825-30.
    View PubMed
  65. Blanchard MJ, Laack NN. Factors associated with local control in inflammatory breast cancer. J Clin Oncol. 2012 Sep 20; 30: (27_suppl)126.
    View PubMed
  66. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012 May; 87(5):475-87.
    View PubMed
  67. Caine C, Mehta MP, Laack NN, Gondi V. Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review. Expert Rev Anticancer Ther. 2012 May; 12: (5)655-67.
    View PubMed
  68. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e803-9. Epub 2012 Feb 11.
    View PubMed
  69. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22.
    View PubMed
  70. Bram RJ, Laack NNI. Protons: Moving therapy for hodgkin lymphoma in a positive direction. ONCOLOGY (United States). 2012; 26(5).
  71. Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr, North Central Cancer Treatment Group and Mayo Clinic. CHODBVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81: (2)476-82.
    View PubMed
  72. Stauder MC, Laack NN, Moir CR, Schomberg PJ. Excellent local control and survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long-term follow-up of the Mayo Clinic experience. J Pediatr Hematol Oncol. 2011 Jul; 33(5):350-5.
    View PubMed
  73. Laack TA, Thompson KM, Kofler JM, Bellolio MF, Sawyer MD, Laack NN. Comparison of trauma mortality and estimated cancer mortality from computed tomography during initial evaluation of intermediate-risk trauma patients. J Trauma. 2011 Jun; 70: (6)1362-5.
    View PubMed
  74. Mascarenhas L, Felgenhauer JL, Bond MC, Femino JD, Laack NN, Ranganathan S, Krailo MD, Marina N, Children's Oncology Group. Pilot study of adding vincristine, topotecan, and cyclophosphamide to interval-compressed chemotherapy in newly diagnosed patients with localized Ewing sarcoma family of tumors: A Children's Oncology Group trial. J Clin Oncol. 2011 May 20; 29: (15_suppl)9526.
    View PubMed
  75. Robinson SI, Ahmed SK, Laack NN, Rose PS, Okuno SH. Clinical outcomes of adult patients with relapsed Ewing sarcoma: A 30-year single institution experience. J Clin Oncol. 2011 May 20; 29: (15_suppl)10041.
    View PubMed
  76. Rao AA, Laack NN, Giannini C, Wetmore C. Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010 Aug; 55(2):290-4.
    View PubMed
  77. Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys. 2010 Aug 1; 77(5):1449-56. Epub 2010 Jan 04.
    View PubMed
  78. Schomas DA, Laack NN, Brown PD. Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. Cancer. 2009 Sep 01; 115: (17)3969-78.
    View PubMed
  79. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, Giannini C, Brown PD. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009 Aug; 11: (4)437-45.
    View PubMed
  80. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct; 9(10):993-1001.
    View PubMed
  81. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan; 83(1):97-112.
    View PubMed
  82. Long HJ 3rd, Laack NN, Gostout BS. Prevention, diagnosis, and treatment of cervical cancer. Mayo Clin Proc. 2007 Dec; 82(12):1566-74.
    View PubMed
  83. Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65: (5)1429-39.
    View PubMed
  84. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC, North Central Cancer Treatment Group. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63: (4)1175-83.
    View PubMed
  85. Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol. 2004 Oct; 31: (5)702-13.
    View PubMed
  86. De Leon DD, Issa N, Nainani S, Asmerom Y. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II). Horm Metab Res. 1999 Feb-Mar; 31: (2-3)142-7.
    View PubMed